An announcement from Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) is now available.
Zylox-Tonbridge Medical Technology Co., Ltd. announced that it has received approval from the Hong Kong Stock Exchange to dis-apply certain listing rules, resulting in the removal of the ‘B’ marker from its stock name. This change reflects the company’s compliance with market capitalization and revenue requirements, signifying its growth and stability in the market.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a leading interventional medical device company based in China. The company focuses on developing and manufacturing medical devices for interventional procedures, having been listed on the Main Board of the Stock Exchange since July 2021.
Average Trading Volume: 737,035
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.74B
Find detailed analytics on 2190 stock on TipRanks’ Stock Analysis page.